Profile data is unavailable for this security.
About the company
Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is engaged in the research, development, manufacture and marketing of pharmaceuticals. Diagnostic reagents business segment is engaged in the research, development, manufacture and marketing of diagnostic reagents and equipment, as well as the provision of inspection service. The Company's main pipeline includes OBP-301 (Telomelysin), an oncolytic virus; OBP-801, an epigenetic anticancer drug and OBP-601 for the treatment of human immunodeficiency virus (HIV) infection, among others.
- Revenue in JPY (TTM)63.04m
- Net income in JPY-1.94bn
- Incorporated2004
- Employees34.00
- LocationOncolys Biopharma IncToranomon Towers Office4-1-28, ToranomonMINATO-KU 105-0001JapanJPN
- Phone+81 354721578
- Fax+81 354721488
- Websitehttps://www.oncolys.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TMS Co Ltd | 0.00 | -960.04m | 9.87bn | 14.00 | -- | 2.86 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | -- | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -11.51 | -- | -- | -- |
Stella Pharma Corp | 254.09m | -765.17m | 10.18bn | 46.00 | -- | 3.81 | -- | 40.06 | -25.23 | -25.23 | 8.32 | 85.55 | 0.0637 | 0.0456 | 3.58 | 5,523,718.00 | -19.18 | -- | -20.37 | -- | 82.76 | -- | -301.14 | -- | 11.90 | -1,173.12 | 0.2671 | -- | 128.85 | -- | -1.45 | -- | -- | -- |
3-D Matrix Ltd | 3.74bn | -1.06bn | 10.21bn | 108.00 | -- | 16.14 | -- | 2.73 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
Linical Co Ltd | 12.52bn | 680.40m | 10.24bn | 759.00 | 13.74 | 1.20 | 8.61 | 0.8181 | 30.12 | 30.12 | 554.28 | 346.38 | 0.7251 | -- | 3.99 | 16,494,230.00 | 3.94 | 4.71 | 6.55 | 7.23 | 33.10 | 31.60 | 5.43 | 5.98 | -- | 17,809.03 | 0.2793 | 45.36 | 8.32 | 6.55 | 27.06 | -4.97 | -33.01 | 4.94 |
AnGes Inc | 152.99m | -7.44bn | 10.67bn | 145.00 | -- | 0.3726 | -- | 69.72 | -39.40 | -39.40 | 0.8083 | 131.52 | 0.0045 | 0.1037 | 8.40 | 1,055,069.00 | -21.97 | -28.50 | -25.69 | -33.14 | 12.71 | 39.42 | -4,861.66 | -6,726.82 | 1.75 | -- | 0.0137 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
KOEI CHEMICAL COMPANY, LIMITED | 18.49bn | 62.58m | 11.10bn | 387.00 | 177.03 | 0.5104 | 3.77 | 0.6003 | 12.79 | 12.79 | 3,779.78 | 4,437.99 | 0.4599 | 1.30 | 4.51 | 47,770,930.00 | 0.1557 | 3.76 | 0.206 | 4.68 | 24.91 | 24.12 | 0.3385 | 6.66 | 0.5356 | 1.77 | 0.3089 | 35.80 | 7.55 | 0.4997 | -26.56 | -33.82 | 15.68 | 20.11 |
Medinet Co Ltd | 724.63m | -1.41bn | 11.54bn | 98.00 | -- | 1.97 | -- | 15.93 | -6.31 | -6.31 | 3.23 | 22.88 | 0.1224 | 11.93 | 3.61 | 7,394,143.00 | -23.74 | -21.05 | -24.75 | -22.47 | 17.72 | 28.75 | -193.90 | -135.40 | 19.58 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
ReproCell Inc | 2.51bn | -217.49m | 11.99bn | 92.00 | -- | 1.47 | -- | 4.78 | -2.56 | -2.56 | 29.48 | 90.90 | 0.3008 | 4.86 | 7.44 | 27,247,390.00 | -2.61 | -9.37 | -2.80 | -10.11 | 43.55 | 38.78 | -8.68 | -38.12 | 11.94 | -- | 0.00 | -- | 32.16 | 26.10 | 46.91 | -- | 28.24 | -- |
Nano Mrna Co Ltd | 164.39m | -1.05bn | 12.53bn | 17.00 | -- | 3.60 | -- | 76.22 | -14.94 | -14.94 | 2.34 | 49.40 | 0.0295 | 18.96 | 2.60 | 9,669,765.00 | -18.85 | -25.13 | -23.29 | -26.04 | 80.67 | 84.69 | -638.22 | -538.31 | 8.95 | -- | 0.2418 | -- | -23.42 | -4.84 | 30.33 | -- | -- | -- |
RaQualia Pharma Inc | 1.90bn | -323.66m | 12.94bn | 67.00 | -- | 2.11 | -- | 6.81 | -14.99 | -14.99 | 87.98 | 283.05 | 0.2896 | 3.13 | 3.15 | 28,376,150.00 | -4.93 | 2.13 | -5.29 | 2.26 | 87.11 | 88.49 | -17.02 | 5.32 | 12.35 | -- | 0.0567 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
Healios KK | 121.00m | -3.82bn | 13.97bn | 64.00 | -- | 3.00 | -- | 115.46 | -55.07 | -55.07 | 1.78 | 51.71 | 0.008 | -- | 0.3929 | 1,890,625.00 | -25.27 | -23.55 | -35.99 | -28.52 | 83.47 | -- | -3,152.89 | -6,580.16 | -- | -13.68 | 0.6756 | -- | 34.44 | -- | 26.04 | -- | -22.00 | -- |
Oncolys Biopharma Inc | 63.04m | -1.94bn | 14.40bn | 34.00 | -- | 9.15 | -- | 228.44 | -108.23 | -108.23 | 3.54 | 75.10 | 0.0269 | 2.19 | 0.3001 | 1,854,059.00 | -82.64 | -45.75 | -97.13 | -51.86 | 48.55 | 60.46 | -3,075.14 | -233.66 | 5.15 | -- | 0.1761 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
Ohki Healthcare Holdings Co Ltd | 327.51bn | 2.35bn | 14.49bn | 576.00 | 6.05 | 0.538 | 5.46 | 0.0443 | 170.32 | 170.32 | 23,747.19 | 1,914.31 | 2.37 | 11.64 | 4.27 | 568,593,700.00 | 1.65 | 1.95 | 7.98 | 9.11 | 5.20 | 7.12 | 0.6962 | 0.7539 | 0.8536 | -- | 0.19 | 13.28 | 9.45 | 4.91 | 124.49 | -1.16 | -1.27 | 9.46 |
Microwave Chemical Co Ltd | 1.89bn | 98.88m | 17.11bn | 59.00 | 246.02 | 10.02 | 97.16 | 9.04 | 4.45 | 4.45 | 116.78 | 109.32 | 0.6526 | 9.37 | 6.53 | 32,055,120.00 | 3.41 | -- | 4.65 | -- | 54.51 | -- | 5.23 | -- | 2.65 | 11.24 | 0.2309 | -- | 41.24 | -- | 168.39 | -- | -- | -- |
TAIKO PHARMACEUTICAL CO LTD | 6.12bn | -3.61bn | 18.03bn | 208.00 | -- | 2.64 | -- | 2.95 | -73.48 | -73.48 | 129.22 | 134.92 | 0.433 | 2.13 | 3.24 | 29,423,080.00 | -25.54 | -- | -32.19 | -- | 42.11 | -- | -58.99 | -- | 2.54 | -- | 0.3256 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Oncolys Biopharma Inc's reporting currency: Japanese Yen JPY
Holder | Shares | % Held |
---|---|---|
Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 82.20k | 0.41% |
Data from 19 Apr 2024 - 19 Apr 2024Source: FactSet Research Systems Inc.